Clinical Trial Update: Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 trial evaluating bortezomib in combination with CHOP given every two weeks for advanced diffuse large B-cell lymphoma; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Bortezomib (bortezomib)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Asan Medical Center | Conditions: Lymphoma, Large-Cell, Diffuse, Lymphoma, B-Cell | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-03-14